STOCK MARKET BSE NSE

Rumours on vaccines can lead to penal action as Centre asks states to be vigilant against ‘misinformation’

The home secretary urged the states to put in place a mechanism to check the spread of rumours and also asked them to promptly disseminate factual messages regarding the issues.

Published: 26th January 2021 07:49 AM  |   Last Updated: 26th January 2021 08:57 AM   |  A+A-

Employees prepare themselves before getting inside a lab where Covishield, AstraZeneca-Oxford's Covid-19 coronavirus vaccine is being manufactured, at India's Serum Institute.

Employees prepare themselves before getting inside a lab where Covishield, AstraZeneca-Oxford's Covid-19 coronavirus vaccine is being manufactured, at India's Serum Institute. (Photo | AFP)

By Express News Service

NEW DELHI: The Centre has asked all states and Union Territories to take penal action against those spreading ‘misinformation’ and ‘ill-informed rumours’ against Covid-19 vaccines.

“Penal action may be taken against the people and organisations found to have indulged in such activities, under the relevant provisions of the Disaster Management Act, 2005 and the Indian Penal Code, 1860,” Union home secretary Ajay Kumar Bhalla said.

Rumours are circulating on social and other media, creating doubts about the safety and efficacy of these vaccines, Bhalla said, stressing that the two vaccines cleared by India are safe.

“Rumour mongering, particularly by vested interests, can create unwarranted doubts among people at large, and there is therefore, a need to check such kinds of unfounded scare mongering relating to the safety and immunogenicity of the vaccines,” Bhalla’s letter states.

The home secretary urged the states to put in place a mechanism to check the spread of rumours and also asked them to promptly disseminate factual messages regarding the issues.

The National Regulatory Authority declared safe two vaccines — AstraZeneca Covishield made by local partner Serum Institute and Bharat Biotech’s Covaxin — following which India’s vaccination drive started on January 16.

Doctors in some states had expressing concern over being inoculated with Covaxin, which saw a bit of controversy after it got the green light on a ‘clinical trial mode’, even though the third phase of its trials is still ongoing.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp